YIDAO BIOTECHNOLOGY
Yidao Biotechnology research and develops vaccines and biomedical products. It focuses on the research and development of a variety of vaccines such as recombinant protein antigen vaccine, new virus vector vaccine, messenger RNA vaccine, and vaccine adjuvant platforms, providing vaccines to meet the needs of human health in both domestic and international markets. The Suzhou, Jiangsu-based biotech company was established in 2017.
YIDAO BIOTECHNOLOGY
Industry:
Biotechnology Health Care Life Science Pharmaceutical Product Research
Founded:
2017-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.immune-path.com
Status:
Active
Total Funding:
581.77 M CNY
Similar Organizations
AgroDesign Studio
AgroDesign Studio conducts research and development of pesticides using active ingredient compounds.
Arinna Lifesciences
Arinna Lifesciences is a manufacturer of pharmaceutical products.
Luxna Biotech
Luxana Biotech is established to contribute to medical treatment for suffering patients, .
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Sana Biotechnology
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Sciwind Biosciences
Sciwind Biosciences is a drug research and development company for metabolic diseases.
Sinovent
Sinovent is engaged in the technical development, consulting, and services of biological medicines.
ThunderBio Innovation
ThunderBio Innovation engages in business includes tumor screening based on the digital biopsy technology of microfluidic chip, etc.
YEASEN Biotechnology
YEASEN commitment to developing and producing high-quality enzyme products
Current Employees Featured
Li Shi Chairman & Chief Executive Officer @ Yidao Biotechnology
Chairman & Chief Executive Officer
Founder
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Yidao Biotechnology
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Yidao Biotechnology
Northern Light Venture Capital
Northern Light Venture Capital investment in Venture Round - Yidao Biotechnology
Official Site Inspections
http://www.immune-path.com
- Host name: ec2-3-0-89-91.ap-southeast-1.compute.amazonaws.com
- IP address: 3.0.89.91
- Location: Singapore Singapore
- Latitude: 1.2929
- Longitude: 103.8547
- Timezone: Asia/Singapore
- Postal: 18
More informations about "Yidao Biotechnology"
怡道生物科技（苏州）有限公司
公司取得国内首个国产重组带状疱疹疫苗临床批件及九价重组人乳头瘤病毒疫苗临床批件. 2020年7月24日，公司的重组带状疱疹疫苗（cho细胞）和九价重组人乳头瘤病毒疫苗（毕赤酵母） …See details»
走进怡道-怡道生物科技（苏州）有限公司 - immune-path.com
怡道生物科技（苏州）有限公司成立于2017年，是一家由国家特聘专家领衔、海内外疫苗研发和医药企业精英团队创建的生物 ...See details»
管理团队-怡道生物科技（苏州）有限公司 - immune-path.com
怡道生物管理团队由有多年海内外疫苗研发和医药企业管理经验地精英团队组成，平均专业经验超过20年，经历了国际和国内疫苗工业界的早期初始增长，到技术突破带来的高速发展的完整历 …See details»
ImmunePath Inc Company Profile, Financial and Strategic
ImmunePath, Inc., a biotechnology company, specializes in developing stem cell based therapeutics for diseases of the immune system. The company was founded in 2010 and is …See details»
史力 - Chairman of the Board of Directors - Immune-Path ... - 领英
Immune-Path Biotechnology - Chairman of the Board · A Ph.D. of pharma industrial professional with over 35 years of USA and China experience in bio-pharmaceutical product development …See details»
Yidao Biotechnology (Suzhou) Co., Ltd. - synapse.zhihuiya.com
了解Yidao Biotechnology (Suzhou) Co., Ltd. (怡道生物科技（苏州）有限公司)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验，疾病领域:感染，肿瘤，技术平台:预防性疫苗，治 …See details»
ImmunePath - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. ImmunePath . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Total Products Active 4. Active Tech Count 1. About. …See details»
发展历程-怡道生物科技（苏州）有限公司 - immune …
1、启动产业化基地建设； 2、启动yd101 i/ii期临床； 3、完成c轮融资，由启明创投、奥博资本领投； 4、 获得姑苏重大创新团队、江苏省双创团队See details»
怡道生物-动脉网 - vbdata.cn
Mar 16, 2017 怡道生物科技（苏州）有限公司成立于2017年，是一家由国家特聘专家领衔、海内外疫苗研发和医药企业精英团队创建的生物技术公司。公司是由多家国内外顶级基金，包括礼 …See details»
Immune-Path Biotech - China Daily
Immune-Path Biotech has been focusing on the research and development of new-type preventative and therapeutic vaccines for humans, as well as the industrialization of biomedical products. The company held a groundbreaking …See details»
Board Chairman and Officer @ Immune-Path Biotechnology
史力, based in Shanghai, China, is currently a Board Chairman and Officer at Immune-Path Biotechnology. 史力 brings experience from previous roles at UCSC, Scripps, Merck & Co., …See details»
ImmunePath - Crunchbase
ImmunePath is a biotechnology company that develops stem cell based therapeutics based in Menlo Park, California.See details»
Immune path biotechnology suzhou co ltdPatents | PatentGuru
Assignee: IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD. IPC: C07K14/04 Abstract: Provided are an immunogenic varicella-zoster virus gE protein mutant and a coding gene …See details»
Immune System Dynamics: Components and Communication …
Jan 11, 2025 Cytokines serve as the immune system’s messengers, intricately modulating the body’s response to various challenges. These small proteins are secreted by immune cells …See details»
战略合作-怡道生物科技（苏州）有限公司 - immune-path.com
知识产权战略. 公司是以科技、创新为主导的高科技企业，在进行研发创新的同时，也注重知识产权保护。公司已建立起完善的知识产权保护体系，以此为基础，公司将继续拓展其他在研项目 …See details»
An introduction to immunology and immunopathology - PubMed
Sep 12, 2018 Beyond structural and chemical barriers to pathogens, the immune system has two fundamental lines of defense: innate immunity and adaptive immunity. Innate immunity is …See details»
Immunology Pathways | Inflammation & Autoimmune Diseases
Immunology is a science dedicated to investigating host defense mechanisms and immune cell functions under physiological and pathological conditions. This includes research on both the …See details»
Constructing a prognostic model based on MPT-related genes and ...
3 days ago Di erential expr ession analysis reveals variations in 13 immune path-ways between high-risk and low-risk cohorts (G). Discrepancies in the expression levels of PD-1/PD-L1/PD …See details»
主要产品管线-怡道生物科技（苏州）有限公司
公司名称： 怡道生物科技（苏州）有限公司 地址： 江苏省苏州市高新区建林路407号 邮箱： shaaiqin@immune-path.comSee details»
The immunopathogenesis of SARS-CoV-2 infection: Overview of …
4 days ago Devising strategies to generate longer-lived protection from vaccines, through more persistent antibody and/or cellular immune responses, is an important aim. Greater …See details»